Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Though the study of AI in lung cancer screening is not new, prior research has been retrospective in nature, making it challenging to determine the impact.
Mandates for universal ECG screening are gaining momentum as a way to combat the risk of SCA. However, the ACC warned, modern healthcare systems were not built to withstand such a rise in demand. These mandates will also result in higher costs and other unintended consequences.
The Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit was developed with the intention of increasing access to screening and supporting prostate health in the Black community.
Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.
Non-white individuals and people living in less educated, lower income areas are more likely to receive an advanced lung cancer diagnosis, such as stage 4 disease.
Digital breast tomosynthesis exams produce fewer false positive results than standard two-dimensional mammography, though not substantially, experts shared recently in JAMA Open Network.
Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging.
Current bone age-based methods of growth prediction in children are inaccurate and frequently overestimate final height, experts explained in Radiology.
In a new video, Evans Pappas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT.